Isocitrate Dehydrogenase-1 Gene

What the Isocitrate Dehydrogenase-1 Gene Means

The isocitrate dehydrogenase-1 gene, often called the IDH1 gene, is a part of your body's instructions for making a protein that helps cells break down fats to create energy. This protein also helps protect cells from harmful molecules that can cause damage. The gene is found in many types of cells and plays an important role in normal cell function.

Why Changes in the IDH1 Gene Matter in Cancer

Sometimes, the IDH1 gene can have mutations, which means changes in its usual structure. These mutations have been found in several types of cancer, including acute myelogenous leukemia (AML), myelodysplastic syndromes, and certain brain cancers. When the IDH1 gene is mutated, it can cause cells to behave abnormally, growing and spreading in ways that lead to cancer. Because these mutations affect how cells work, they can be important in understanding the cancer’s behavior and deciding on treatment options.

What Patients Might See or Hear About the IDH1 Gene

You might hear about the IDH1 gene during discussions about your diagnosis, test results, or treatment plan. It may also appear on medical reports, clinical trial information, or drug fact sheets. The gene is sometimes called the isocitrate dehydrogenase-1 gene, so both names refer to the same thing. If your cancer has been tested for this mutation, your care team may explain what it means for your treatment.

How Doctors Use IDH1 Gene Information

Doctors may test for mutations in the IDH1 gene to help guide treatment decisions. If a mutation is found, targeted therapies such as ivosidenib (Tibsovo) or olutasidenib (Rezlidhia) might be options. These drugs work by blocking the abnormal protein made by the mutated gene, which can help slow or stop cancer growth. Testing for IDH1 mutations can also be part of clinical trials exploring new treatments.

What an IDH1 Gene Mutation Does Not Automatically Mean

Finding a mutation in the IDH1 gene does not by itself provide a full diagnosis or predict exactly how the cancer will behave. It is one piece of information among many that doctors use to understand the cancer and plan treatment. Not all cancers have this mutation, and not all patients with the mutation will have the same experience or response to treatment.

Common Questions to Ask Your Care Team

If the IDH1 gene mutation comes up in your care, you might ask: What does this mutation mean for my cancer? Are there treatments that target this mutation? How will this affect my treatment plan or outlook? Should I consider genetic testing or clinical trials? Understanding how this gene relates to your specific situation can help you feel more informed and involved in your care.

Understanding the Term in Context

Because the IDH1 gene can be listed under different names and appears in various parts of medical records, it’s important to ask your care team to explain what it means in your specific case. This helps avoid confusion and ensures you get clear information about your diagnosis and treatment options.

Important Safety and Next Steps

This information is educational and does not replace medical advice. The presence of an IDH1 gene mutation and related treatments should be discussed with your healthcare providers, who can explain what is safe and appropriate for your individual situation. If you see this term in your medical records or hear it during your care, the best next step is to ask your care team what it means for you personally.